5083050
SARS Nucleocapsid Protein Antibody, Novus Biologicals™
Rabbit Polyclonal Antibody has been used in 2 publications
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
SARS Nucleocapsid Protein
Dilution
Western Blot 1:100-1:2000, ELISA 1:100-1:2000
Classification
Polyclonal
Form
Purified
Regulatory Status
RUO
Formulation
PBS containing 0.5% BSA with 0.05% Sodium Azide
Gene Alias
COVID-19 nucleocapsid protein, N, N protein, N structural protein, NC, Nucleocapsid protein, Nucleoprotein, Protein N, SARS coronavirus N protein, SARS coronavirus nucleocapsid protein, SARS CoV, SARS CoV N protein, SARS CoV nucleocapsid protein, SARS N protein, SARS Nucleoprotein, SARSCoV, SARSCoV N protein, SARSCoV nucleocapsid protein, SARSCOV2 N protein, SARS-COV-2 nucleocapsid protein, Severe acute respiratory syndrome
Immunogen
The antibody was developed by immunizing Rabbit with a synthetic peptide corresponding to amino acids 84-99 (C-IGYYRRATRRIRGGDG) from the N (SARS Nucleocapsid) for the Human SARS coronavirus (Genbank accession no. YP_009724397.2)
Primary or Secondary
Primary
Content And Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Concentration
0.5 mg/mL
Applications
Western Blot, ELISA
Conjugate
Unconjugated
Host Species
Rabbit
Target Species
SARS-CoV
Gene Accession No.
NP_006504
Gene ID (Entrez)
6301
Isotype
IgG
Purification Method
Protein A purified
Related Products
Description
- SARS Nucleocapsid Protein Polyclonal specifically detects SARS Nucleocapsid Protein in SARS-CoV samples
- It is validated for Western Blot, ELISA.
Compare Similar Items
Show Difference
Antigen: SARS Nucleocapsid Protein
Dilution: Western Blot 1:100-1:2000, ELISA 1:100-1:2000
Classification: Polyclonal
Form: Purified
Regulatory Status: RUO
Formulation: PBS containing 0.5% BSA with 0.05% Sodium Azide
Gene Alias: COVID-19 nucleocapsid protein, N, N protein, N structural protein, NC, Nucleocapsid protein, Nucleoprotein, Protein N, SARS coronavirus N protein, SARS coronavirus nucleocapsid protein, SARS CoV, SARS CoV N protein, SARS CoV nucleocapsid protein, SARS N protein, SARS Nucleoprotein, SARSCoV, SARSCoV N protein, SARSCoV nucleocapsid protein, SARSCOV2 N protein, SARS-COV-2 nucleocapsid protein, Severe acute respiratory syndrome
Immunogen: The antibody was developed by immunizing Rabbit with a synthetic peptide corresponding to amino acids 84-99 (C-IGYYRRATRRIRGGDG) from the N (SARS Nucleocapsid) for the Human SARS coronavirus (Genbank accession no. YP_009724397.2)
Primary or Secondary: Primary
Content And Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Concentration: 0.5 mg/mL
Applications: Western Blot, ELISA
Conjugate: Unconjugated
Host Species: Rabbit
Target Species: SARS-CoV
Gene Accession No.: NP_006504
Gene ID (Entrez): 6301
Isotype: IgG
Purification Method: Protein A purified
Antigen:
SARS Nucleocapsid Protein
Dilution:
Western Blot 1:100-1:2000, ELISA 1:100-1:2000
Classification:
Polyclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
PBS containing 0.5% BSA with 0.05% Sodium Azide
Gene Alias:
COVID-19 nucleocapsid protein, N, N protein, N structural protein, NC, Nucleocapsid protein, Nucleoprotein, Protein N, SARS coronavirus N protein, SARS coronavirus nucleocapsid protein, SARS CoV, SARS CoV N protein, SARS CoV nucleocapsid protein, SARS N protein, SARS Nucleoprotein, SARSCoV, SARSCoV N protein, SARSCoV nucleocapsid protein, SARSCOV2 N protein, SARS-COV-2 nucleocapsid protein, Severe acute respiratory syndrome
Immunogen:
The antibody was developed by immunizing Rabbit with a synthetic peptide corresponding to amino acids 84-99 (C-IGYYRRATRRIRGGDG) from the N (SARS Nucleocapsid) for the Human SARS coronavirus (Genbank accession no. YP_009724397.2)
Primary or Secondary:
Primary
Content And Storage:
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Concentration:
0.5 mg/mL
Applications:
Western Blot, ELISA
Conjugate:
Unconjugated
Host Species:
Rabbit
Target Species:
SARS-CoV
Gene Accession No.:
NP_006504
Gene ID (Entrez):
6301
Isotype:
IgG
Purification Method:
Protein A purified
Antigen: SARS Nucleocapsid Protein
Dilution: Western Blot 1:100-1:2000, Immunohistochemistry reported in scientific literature (PMID 32396922), Immunocytochemistry/Immunofluorescence 1:10-1:500. Use reported in scientific literature (Mossel et al (2008)), Immunohistochemistry-Paraffin reported in scientific literature (PMID 24725942), SDS-Page reported in scientific literature (PMID 34880383), Dual RNAscope ISH-IHC
Classification: Polyclonal
Form: Purified
Regulatory Status: RUO
Formulation: PBS with 0.02% Sodium Azide
Gene Alias: 2019-nCoV Nucleocapsid Protein, COVID-19 N protein, N, N protein, N structural protein, NC, Nucleocapsid protein, Nucleoprotein, Protein N, SARS coronavirus N protein, SARS coronavirus nucleocapsid protein, SARS CoV, SARS CoV N protein, SARS CoV nucleocapsid protein, SARS N protein, SARS Nucleoprotein, SARSCoV, SARSCoV N protein, SARSCoV nucleocapsid protein, SARS-CoV-2 N protein, Severe acute respiratory syndrome
Immunogen: The antibody was developed by immunizing Rabbit with a synthetic peptide corresponding to amino acids 399-411 (DLDDFSKQLQQSM-C) from the N (SARS Nucleocapsid) for the Human SARS coronavirus (Genbank accession no. YP_009724397.2)
Primary or Secondary: Primary
Content And Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Concentration: 1.0 mg/mL
Applications: Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), In Situ Hybridization (ISH)
Conjugate: Unconjugated
Host Species: Rabbit
Target Species: SARS-CoV-2, SARS-CoV, Virus
Gene Accession No.: NP_006504.2
Gene ID (Entrez): __
Isotype: IgG
Purification Method: Immunogen affinity purified
Antigen:
SARS Nucleocapsid Protein
Dilution:
Western Blot 1:100-1:2000, Immunohistochemistry reported in scientific literature (PMID 32396922), Immunocytochemistry/Immunofluorescence 1:10-1:500. Use reported in scientific literature (Mossel et al (2008)), Immunohistochemistry-Paraffin reported in scientific literature (PMID 24725942), SDS-Page reported in scientific literature (PMID 34880383), Dual RNAscope ISH-IHC
Classification:
Polyclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
PBS with 0.02% Sodium Azide
Gene Alias:
2019-nCoV Nucleocapsid Protein, COVID-19 N protein, N, N protein, N structural protein, NC, Nucleocapsid protein, Nucleoprotein, Protein N, SARS coronavirus N protein, SARS coronavirus nucleocapsid protein, SARS CoV, SARS CoV N protein, SARS CoV nucleocapsid protein, SARS N protein, SARS Nucleoprotein, SARSCoV, SARSCoV N protein, SARSCoV nucleocapsid protein, SARS-CoV-2 N protein, Severe acute respiratory syndrome
Immunogen:
The antibody was developed by immunizing Rabbit with a synthetic peptide corresponding to amino acids 399-411 (DLDDFSKQLQQSM-C) from the N (SARS Nucleocapsid) for the Human SARS coronavirus (Genbank accession no. YP_009724397.2)
Primary or Secondary:
Primary
Content And Storage:
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Concentration:
1.0 mg/mL
Applications:
Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), In Situ Hybridization (ISH)
Conjugate:
Unconjugated
Host Species:
Rabbit
Target Species:
SARS-CoV-2, SARS-CoV, Virus
Gene Accession No.:
NP_006504.2
Gene ID (Entrez):
__
Isotype:
IgG
Purification Method:
Immunogen affinity purified
Antigen: SARS Nucleocapsid Protein
Dilution: Western Blot 1:100-1:2000, Immunohistochemistry reported in scientific literature (PMID 32396922), Immunocytochemistry/Immunofluorescence 1:10-1:500. Use reported in scientific literature (Mossel et al (2008)), Immunohistochemistry-Paraffin reported in scientific literature (PMID 24725942), SDS-Page reported in scientific literature (PMID 34880383), Dual RNAscope ISH-IHC
Classification: Polyclonal
Form: Purified
Regulatory Status: RUO
Formulation: PBS with 0.02% Sodium Azide
Gene Alias: 2019-nCoV Nucleocapsid Protein, COVID-19 N protein, N, N protein, N structural protein, NC, Nucleocapsid protein, Nucleoprotein, Protein N, SARS coronavirus N protein, SARS coronavirus nucleocapsid protein, SARS CoV, SARS CoV N protein, SARS CoV nucleocapsid protein, SARS N protein, SARS Nucleoprotein, SARSCoV, SARSCoV N protein, SARSCoV nucleocapsid protein, SARS-CoV-2 N protein, Severe acute respiratory syndrome
Immunogen: The antibody was developed by immunizing Rabbit with a synthetic peptide corresponding to amino acids 399-411 (DLDDFSKQLQQSM-C) from the N (SARS Nucleocapsid) for the Human SARS coronavirus (Genbank accession no. YP_009724397.2)
Primary or Secondary: Primary
Content And Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Concentration: 1.0 mg/mL
Applications: Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), In Situ Hybridization (ISH)
Conjugate: Unconjugated
Host Species: Rabbit
Target Species: SARS-CoV-2, SARS-CoV, Virus
Gene Accession No.: NP_006504.2
Gene ID (Entrez): __
Isotype: IgG
Purification Method: Immunogen affinity purified
Antigen:
SARS Nucleocapsid Protein
Dilution:
Western Blot 1:100-1:2000, Immunohistochemistry reported in scientific literature (PMID 32396922), Immunocytochemistry/Immunofluorescence 1:10-1:500. Use reported in scientific literature (Mossel et al (2008)), Immunohistochemistry-Paraffin reported in scientific literature (PMID 24725942), SDS-Page reported in scientific literature (PMID 34880383), Dual RNAscope ISH-IHC
Classification:
Polyclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
PBS with 0.02% Sodium Azide
Gene Alias:
2019-nCoV Nucleocapsid Protein, COVID-19 N protein, N, N protein, N structural protein, NC, Nucleocapsid protein, Nucleoprotein, Protein N, SARS coronavirus N protein, SARS coronavirus nucleocapsid protein, SARS CoV, SARS CoV N protein, SARS CoV nucleocapsid protein, SARS N protein, SARS Nucleoprotein, SARSCoV, SARSCoV N protein, SARSCoV nucleocapsid protein, SARS-CoV-2 N protein, Severe acute respiratory syndrome
Immunogen:
The antibody was developed by immunizing Rabbit with a synthetic peptide corresponding to amino acids 399-411 (DLDDFSKQLQQSM-C) from the N (SARS Nucleocapsid) for the Human SARS coronavirus (Genbank accession no. YP_009724397.2)
Primary or Secondary:
Primary
Content And Storage:
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Concentration:
1.0 mg/mL
Applications:
Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), In Situ Hybridization (ISH)
Conjugate:
Unconjugated
Host Species:
Rabbit
Target Species:
SARS-CoV-2, SARS-CoV, Virus
Gene Accession No.:
NP_006504.2
Gene ID (Entrez):
__
Isotype:
IgG
Purification Method:
Immunogen affinity purified
Antigen: SARS Nucleocapsid Protein
Dilution: Western Blot 1:100-1:2000, Simple Western 1:50, ELISA 1:100-1:2000, Immunohistochemistry, Immunocytochemistry/Immunofluorescence reported in scientific literature (PMID 16014910), Immunohistochemistry-Paraffin, Dual RNAscope ISH-IHC
Classification: Polyclonal
Form: Antisera
Regulatory Status: RUO
Formulation: PBS with 0.05% Sodium Azide
Gene Alias: COVID-19 nucleocapsid protein, N, N protein, N structural protein, NC, Nucleocapsid protein, Nucleoprotein, Protein N, SARS coronavirus N protein, SARS coronavirus nucleocapsid protein, SARS CoV, SARS CoV N protein, SARS CoV nucleocapsid protein, SARS N protein, SARS Nucleoprotein, SARSCoV, SARSCoV N protein, SARSCoV nucleocapsid protein, SARSCOV2 N protein, SARS-COV-2 nucleocapsid protein, SARS-COV-2 Nucleoprotein, Severe acute respiratory syndrome
Immunogen: The antibody was developed by immunizing rabbits with a synthetic peptide corresponding to amino acids 354-370 (NKHIDAYKTFPPTEPKK-C) from the N (SARS Nucleocapsid) for the Human SARS coronavirus (Genbank accession no. YP_009724397.2)
Primary or Secondary: Primary
Content And Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Concentration: 1 mg/mL
Applications: Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), In Situ Hybridization (ISH)
Conjugate: Unconjugated
Host Species: Rabbit
Target Species: SARS-CoV, SARS-CoV-2
Gene Accession No.: NP_006504.2
Gene ID (Entrez): __
Isotype: IgG
Purification Method: Protein G purified
Antigen:
SARS Nucleocapsid Protein
Dilution:
Western Blot 1:100-1:2000, Simple Western 1:50, ELISA 1:100-1:2000, Immunohistochemistry, Immunocytochemistry/Immunofluorescence reported in scientific literature (PMID 16014910), Immunohistochemistry-Paraffin, Dual RNAscope ISH-IHC
Classification:
Polyclonal
Form:
Antisera
Regulatory Status:
RUO
Formulation:
PBS with 0.05% Sodium Azide
Gene Alias:
COVID-19 nucleocapsid protein, N, N protein, N structural protein, NC, Nucleocapsid protein, Nucleoprotein, Protein N, SARS coronavirus N protein, SARS coronavirus nucleocapsid protein, SARS CoV, SARS CoV N protein, SARS CoV nucleocapsid protein, SARS N protein, SARS Nucleoprotein, SARSCoV, SARSCoV N protein, SARSCoV nucleocapsid protein, SARSCOV2 N protein, SARS-COV-2 nucleocapsid protein, SARS-COV-2 Nucleoprotein, Severe acute respiratory syndrome
Immunogen:
The antibody was developed by immunizing rabbits with a synthetic peptide corresponding to amino acids 354-370 (NKHIDAYKTFPPTEPKK-C) from the N (SARS Nucleocapsid) for the Human SARS coronavirus (Genbank accession no. YP_009724397.2)
Primary or Secondary:
Primary
Content And Storage:
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Concentration:
1 mg/mL
Applications:
Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), In Situ Hybridization (ISH)
Conjugate:
Unconjugated
Host Species:
Rabbit
Target Species:
SARS-CoV, SARS-CoV-2
Gene Accession No.:
NP_006504.2
Gene ID (Entrez):
__
Isotype:
IgG
Purification Method:
Protein G purified